Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Fosrenol (Lanthanum Carbonate) Tablets
Company:  Shire Pharmaceutical Development Inc.
Application No.:  021468
Approval Date: 10/26/2004


Date created: January 282005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.